New insights into cerebral small vessel disease and vascular cognitive impairment from MRI

Eric E Smith1, Andrew E Beaudin

  • 1Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.

Abstract

Insights

Advanced MRI techniques aid in early diagnosis of cerebral small vessel disease (SVD) and understanding its link to cognitive impairment. These methods show promise as biomarkers in clinical trials.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • Cerebral small vessel disease (SVD) presents challenges in early diagnosis and understanding its association with cognitive decline.
  • Magnetic Resonance Imaging (MRI) offers potential for assessing SVD-related brain changes.

Purpose of the Study:

  • To review recent MRI research on early SVD diagnosis and its link to cognitive impairment.
  • To explore MRI measurements of blood flow, blood-brain barrier integrity, brain connectivity, and white matter microarchitecture in SVD.
  • To contextualize findings with management recommendations and biomarker use in clinical trials.

Main Methods:

  • Review of MRI studies focusing on cerebral perfusion, cerebrovascular reactivity (CVR), and blood-brain barrier integrity.
  • Analysis of MRI studies examining neuroimaging correlates of SVD-related cognitive dysfunction, including brain connectivity and white matter microarchitecture.
  • Inclusion of novel diffusion tensor imaging (DTI) analysis methods like graph theory and mean diffusivity histograms.

Main Results:

  • MRI can measure alterations in cerebral perfusion, CVR, blood-brain barrier permeability, and white matter microarchitecture in SVD.
  • Reduced cerebral blood flow is linked to increased dementia risk; decreased CVR is an early SVD marker associated with white matter hyperintensity growth.
  • New DTI analysis approaches, including graph theory and mean diffusivity histograms, are emerging for SVD research.

Conclusions:

  • Advanced quantitative neuroimaging techniques are valuable biomarkers in current SVD clinical trials.
  • These techniques, while not yet for routine practice, are advancing SVD research and monitoring.